Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Researchers identify new GPR52 agonists

Oct. 22, 2021

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Oct. 22, 2021

FDG-PET signal is substantially affected by microglial glucose uptake in neurodegenerative diseases

Oct. 21, 2021

Chengdu Novo Sinta Biotechnology describes kappa-opioid receptor agonists

Oct. 20, 2021

SRI International patents new lipoxygenase inhibitors

Oct. 20, 2021

Calpain inhibitor BLD-2736 is protective against spinocerebellar ataxia type 3

Oct. 20, 2021

Orexia and Schrodinger collaborate to discover novel therapeutics targeting OX2 receptor

Oct. 19, 2021

Cannabidiol-carbamate hybrid shows therapeutic potential in models of AD

Oct. 19, 2021

IEM presents new antiparkinsonian compounds

Oct. 18, 2021

Amydis receives NINDS funding to explore presence of ASYN in retina of Parkinson's models

Oct. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...